Stay up-to-date with our latest news

Announcements

Evidation Insights from 165,000 People Show Continued Growth Potential Amid Uneven Adoption in the GLP-1 Market
Among 119,000 surveyed individuals actively trying to lose weight, 24% had ever used prescription medication for weight management and 15% had ever used a GLP-1, suggesting significant room for continued market growth as adoption varies by age, gender, and income.

Evidation Launches Temporal Proteomics Platform to Power Autoimmune Research

Evidation Shares Insights on Real-World GLP-1 Dosing Behaviors from Over 60,000 Individuals

Evidation Appoints Dr. Ghazanfar Khan as Chief Medical Officer

Evidation Appoints Leslie Oley Wilberforce as CEO

Evidation appoints Phil Johnson as Chief Commercial Officer

Trialbee and Evidation partner to accelerate and diversify clinical research recruitment

Rock Health shares findings from weight care survey with Evidation

Frost & Sullivan awards Evidation for its direct-to-participant real world data solutions

Evidation launches MigraineSmart on the Evidation app

Evidation shares real world data on GLP-1 use and social determinants of health at ISPOR 2024

Evidation selected by Our Future Health as participant platform for UK’s largest health research program

BARDA expands partnership with Evidation to validate and improve machine learning models for early detection of influenza-like illness using wearables

About Evidation

Evidation creates new ways to measure and improve health in everyday life. Built upon a foundation of user privacy and control over permissioned health data, Evidation's consumer platform is trusted by millions of individuals—generating data with unprecedented speed, scale, and rigor. We partner with leading healthcare companies to understand health and disease outside the clinic walls. Evidation is working to bring people individualized, proactive, and accessible healthcare—faster. Founded in 2012, Evidation is headquartered in California with employees working around the globe.